Pro-inflammatory cytokine responses at the cellular level

Pro-inflammatory cytokine responses at the cellular level represent a broad physiological process rather than a single molecular target. This process involves the production and secretion of signaling proteins like Tumor Necrosis Factor-alpha (TNF-α), Interleukin-1 (IL-1), and Interleukin-6 (IL-6) by immune cells in response to stimuli such as pathogens or tissue damage (StatPearls, NBK499840). These cytokines bind to specific cell-surface receptors, triggering intracellular signaling cascades—most notably the NF-κB and JAK/STAT pathways—that alter gene expression to promote inflammation and immune cell activation (Nature, s41392-021-00649-3). While these responses are vital for host defense, chronic or excessive activation is a hallmark of autoimmune diseases, chronic inflammatory conditions, and "cytokine storms" seen in severe infections (PubMed, 32785915). Pharmacological strategies aim to dampen these responses by targeting specific components of the pathway, such as the cytokines themselves or the kinases that propagate their signals. Because this term encompasses a wide array of distinct proteins and pathways, it is classified as a biological process rather than a specific therapeutic target.

Other names

Pro-inflammatory signalingCytokine-mediated inflammationCellular inflammatory responseCytokine cascade

Modulation of the inflammatory cascade through the inhibition of specific cytokine ligands, their respective receptors, or downstream intracellular signaling molecules such as Janus kinases (Nature, s41392-021-00649-3).